ABBV vs RVTY
By Alex · Tickerpine
AbbVie Inc. vs Revvity, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | RVTY |
|---|---|---|
| Price | $253.35 | $113.02 |
| Market cap | $447.62B | $12.61B |
| P/E ratio | 123.6 | 54.3 |
| ROE | — | 3.23% |
| Profit margin | 5.79% | 8.26% |
| Revenue growth | 12.40% | 7.00% |
| Dividend yield | 2.73% | 0.25% |
| Beta | 0.31 | 1.11 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs RVTY in plain English
- ABBV is the bigger company — about 35.5× the market cap of RVTY.
- RVTY is cheaper on earnings (P/E 54.3 vs 123.6).
- ABBV is growing revenue faster (12% vs 7%).
- ABBV has the higher dividend yield (2.73% vs 0.25%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
RVTY return calculator
See what $1,000 in Revvity, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.